Mohamed Rahamathulla

1.6k total citations · 1 hit paper
66 papers, 1.1k citations indexed

About

Mohamed Rahamathulla is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Mohamed Rahamathulla has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmaceutical Science, 16 papers in Molecular Biology and 13 papers in Biomaterials. Recurrent topics in Mohamed Rahamathulla's work include Drug Solubulity and Delivery Systems (21 papers), Advanced Drug Delivery Systems (16 papers) and Nanoparticle-Based Drug Delivery (12 papers). Mohamed Rahamathulla is often cited by papers focused on Drug Solubulity and Delivery Systems (21 papers), Advanced Drug Delivery Systems (16 papers) and Nanoparticle-Based Drug Delivery (12 papers). Mohamed Rahamathulla collaborates with scholars based in Saudi Arabia, India and Jordan. Mohamed Rahamathulla's co-authors include Umme Hani, Riyaz Ali M. Osmani, Faiyaz Shakeel, H.V. Gangadharappa, Sultan Alshehri, M. Yasmin Begum, Mohammed M. Ghoneim, Mohammed Ghazwani, Mohammed Muqtader Ahmed and Syeda Ayesha Farhana and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Mohamed Rahamathulla

60 papers receiving 1.0k citations

Hit Papers

Biological importance and synthesis of 1,2,3-triazole der... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Rahamathulla Saudi Arabia 18 297 261 256 255 163 66 1.1k
Suhair Sunoqrot Jordan 21 339 1.1× 368 1.4× 361 1.4× 193 0.8× 121 0.7× 53 1.3k
Abdelkader A. Metwally Egypt 19 225 0.8× 357 1.4× 281 1.1× 205 0.8× 155 1.0× 31 1.0k
Rudra Pangeni South Korea 19 268 0.9× 324 1.2× 282 1.1× 170 0.7× 136 0.8× 38 1.3k
Mohamed A. Shaker Egypt 16 225 0.8× 221 0.8× 196 0.8× 144 0.6× 125 0.8× 26 861
Subramanian Natesan India 19 421 1.4× 302 1.2× 247 1.0× 181 0.7× 120 0.7× 52 1.1k
Rongfeng Hu China 20 309 1.0× 408 1.6× 229 0.9× 229 0.9× 105 0.6× 68 1.1k
Meijuan Zou China 18 339 1.1× 266 1.0× 277 1.1× 275 1.1× 177 1.1× 43 1.0k
Hitesh Kulhari India 22 226 0.8× 379 1.5× 402 1.6× 291 1.1× 149 0.9× 53 1.2k
Yedi Herdiana Indonesia 15 257 0.9× 230 0.9× 436 1.7× 223 0.9× 126 0.8× 35 1.0k
Dilpreet Singh India 16 305 1.0× 207 0.8× 180 0.7× 162 0.6× 135 0.8× 116 956

Countries citing papers authored by Mohamed Rahamathulla

Since Specialization
Citations

This map shows the geographic impact of Mohamed Rahamathulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Rahamathulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Rahamathulla more than expected).

Fields of papers citing papers by Mohamed Rahamathulla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Rahamathulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Rahamathulla. The network helps show where Mohamed Rahamathulla may publish in the future.

Co-authorship network of co-authors of Mohamed Rahamathulla

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Rahamathulla. A scholar is included among the top collaborators of Mohamed Rahamathulla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Rahamathulla. Mohamed Rahamathulla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Mohammed Muqtader, et al.. (2025). Detection of COVID-19 with the naked eye using C60-based sensors for isobutyric acid in exhaled air: A DFT/TDDFT study. Diamond and Related Materials. 153. 112013–112013. 2 indexed citations
2.
Satapathy, Bhabani Sankar, Gurudutta Pattnaik, Yahya Alhamhoom, et al.. (2025). Design and Optimization of Trastuzumab-Functionalized Nanolipid Carriers for Targeted Capecitabine Delivery: Anti-Cancer Effectiveness Evaluation in MCF-7 and SKBR3 Cells. International Journal of Nanomedicine. Volume 20. 12075–12102.
4.
Rahamathulla, Mohamed, Sushma Devi, Manish Kumar, et al.. (2025). IRES activation: HK2 and TPI1 glycolytic enzymes play a pivotal role in non-neuronal cell survival under hypoxia. Artificial Cells Nanomedicine and Biotechnology. 53(1). 139–152. 1 indexed citations
5.
Rahamathulla, Mohamed, et al.. (2025). Formulation and Characterization of Nadolol Transdermal Delivery Using 3² Factorial Design: In Vitro and Ex Vivo Evaluation. Journal of Pharmaceutical Innovation. 21(1).
8.
Rahamathulla, Mohamed, Mohammed Muqtader Ahmed, Syeda Ayesha Farhana, et al.. (2024). Box-Behnken Design-Based Optimization and Evaluation of Lipid-Based Nano Drug Delivery System for Brain Targeting of Bromocriptine. Pharmaceuticals. 17(6). 720–720. 12 indexed citations
9.
Alhamhoom, Yahya, et al.. (2023). Synergistic Antihyperglycemic and Antihyperlipidemic Effect of Polyherbal and Allopolyherbal Formulation. Pharmaceuticals. 16(10). 1368–1368. 6 indexed citations
11.
Gupta, N. Vishal, Mohamed Rahamathulla, Mohammed Muqtader Ahmed, et al.. (2023). Subconjunctival therapy by cubic liquid crystalline nanoparticles to deliver Triamcinolone acetonide for the management of diabetic Retinopathy: In vivo evidences. International Journal of Pharmaceutics. 646. 123443–123443. 6 indexed citations
13.
Saisivam, S., et al.. (2023). Design and evaluation of in situ gel eye drops containing nanoparticles of Gemifloxacin Mesylate. Drug Delivery. 30(1). 2185180–2185180. 9 indexed citations
14.
Rahamathulla, Mohamed, et al.. (2023). The Use of Nanoneedles in Drug Delivery: an Overview of Recent Trends and Applications. AAPS PharmSciTech. 24(8). 216–216. 4 indexed citations
15.
Hani, Umme, Riyaz Ali M. Osmani, Ali H. Alamri, et al.. (2023). Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease. Pharmaceutics. 15(1). 221–221. 31 indexed citations
16.
Hagbani, Turki Al, Syed Mohd Danish Rizvi, Talib Hussain, et al.. (2022). Cefotaxime Mediated Synthesis of Gold Nanoparticles: Characterization and Antibacterial Activity. Polymers. 14(4). 771–771. 41 indexed citations
17.
Chidambaram, Kumarappan, et al.. (2022). Mucilage of Coccinia grandis as an Efficient Natural Polymer-Based Pharmaceutical Excipient. Polymers. 14(1). 215–215. 13 indexed citations
18.
Bhosale, Rohit R., Riyaz Ali M. Osmani, Amr S. Abu Lila, et al.. (2021). Ghatti gum-base graft copolymer: a plausible platform for pH-controlled delivery of antidiabetic drugs. RSC Advances. 11(24). 14871–14882. 17 indexed citations
19.
Ghazwani, Mohammed, Umme Hani, Riyaz Ali M. Osmani, et al.. (2021). An Efficient Herbal Approach for Treating Fungal Infection in Cervical Cancer Patients by Developing and Optimizing a Vaginal Suppository. International Journal of Polymer Science. 2021. 1–11. 3 indexed citations
20.
Begum, M. Yasmin, et al.. (2021). Development of Duloxetine Hydrochloride Tablets for Delayed and Complete Release Using Eudragit L 100. International Journal of Polymer Science. 2021. 1–10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026